Back to search

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

Data up to Jan 2025

Published2002
Citations386
References38

Total Citations Per Year

Abstract

References (38)

Cell Signaling by Receptor Tyrosine Kinases

2010 • 7,477 citations

Integrin Signaling

1999 • 3,705 citations

Cell Signaling by Receptor Tyrosine Kinases

2000 • 3,570 citations

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1984 • 2,762 citations

EGFR and cancer prognosis

2001 • 2,068 citations

The urokinase-type plasminogen activator system in cancer metastasis: A review

1997 • 1,561 citations

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

1996 • 1,473 citations

FAK integrates growth-factor and integrin signals to promote cell migration

2000 • 1,215 citations

Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.

1996 • 769 citations

A Requirement for Caveolin-1 and Associated Kinase Fyn in Integrin Signaling and Anchorage-Dependent Cell Growth

1998 • 720 citations

Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival

1998 • 574 citations

Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling

1999 • 520 citations

Urokinase Receptor and Fibronectin Regulate the ERKMAPK to p38MAPK Activity Ratios That Determine Carcinoma Cell Proliferation or Dormancy In Vivo

2001 • 422 citations

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth

2000 • 379 citations

Integrin associated proteins

1998 • 370 citations

Focal adhesion kinase in integrin-mediated signaling

1999 • 345 citations

Fibronectin and Its Integrin Receptors in Cancer

1999 • 338 citations

Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity

1995 • 302 citations

Monoclonal Antibody 9EG7 Defines a Novel β1 Integrin Epitope Induced by Soluble Ligand and Manganese, but Inhibited by Calcium

1995 • 281 citations

Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.

1995 • 270 citations

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

1992 • 253 citations

Tissue structure, nuclear organization, and gene expression in normal and malignant breast.

1999 • 247 citations

Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1.

1954 • 231 citations

Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo

2002 • 220 citations

Integrins and GTPases in tumour cell growth, motility and invasion

1998 • 219 citations

Novel Roles for α3β1 Integrin as a Regulator of Cytoskeletal Assembly and as a Trans-dominant Inhibitor of Integrin Receptor Function in Mouse Keratinocytes

1998 • 207 citations

Trans-dominant inhibition of integrin function.

1996 • 174 citations

The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.

1994 • 171 citations

Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy

1997 • 158 citations

Integrin α5/β1 Mediates Fibronectin-dependent Epithelial Cell Proliferation through Epidermal Growth Factor Receptor Activation

2000 • 144 citations

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.

1992 • 129 citations

The urokinase plasminogen activator system as a novel target for tumour therapy

2000 • 111 citations

Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.

1992 • 104 citations

β2(CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors

1997 • 102 citations

Divalent Cations and Ligands Induce Conformational Changes That Are Highly Divergent among β1 Integrins

1998 • 95 citations

VLA-4 (α4β1) engagement defines a novel activation pathway for β2 integrin–dependent leukocyte adhesion involving the urokinase receptor

2000 • 69 citations

Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters.

1980 • 53 citations

Cleavage of urokinase receptor regulates its interaction with integrins in thyroid cells

1999 • 28 citations

Cited By (0)

Loading...
EGFR is a transducer of the urokinase receptor initiated signal that is required for in… (2002) – Cancer Cell | Metascience Observatory Explorer